First RNAi Therapy Approved by FDA
First RNAi Therapy Approved by FDA
Alnylam’s patisiran interferes with the production of a mutated protein present in people with hereditary transthyretin amyloidosis.
First RNAi Therapy Approved by FDA
First RNAi Therapy Approved by FDA

Alnylam’s patisiran interferes with the production of a mutated protein present in people with hereditary transthyretin amyloidosis.

Alnylam’s patisiran interferes with the production of a mutated protein present in people with hereditary transthyretin amyloidosis.

drug development, business, biotech
Opinion: Learning from Immunotherapy’s Recent Failures
Opinion: Learning from Immunotherapy’s Recent Failures
Luis Felipe Campesato | Aug 1, 2018
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Researchers React to Microsoft’s Acquisition of GitHub
Researchers React to Microsoft’s Acquisition of GitHub
Anna Azvolinsky | Jun 7, 2018
Computational biologists are optimistic that the purchase of the world’s largest hub for open-source computer code will not affect the way they use GitHub for science.
MyHeritage Account Data Compromised in “Cybersecurity Incident”
MyHeritage Account Data Compromised in “Cybersecurity Incident”
Catherine Offord | Jun 6, 2018
A security researcher found the email addresses and encrypted passwords of more than 92 million users of the genealogy site on a private server outside the company.
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
Companies to Help People Sell or Rent Out Their Health Data
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
New Treatments for Phenylketonuria Aim to Loosen Reins on Strict Diet
New Treatments for Phenylketonuria Aim to Loosen Reins on Strict Diet
Diana Kwon | May 29, 2018
Biotechs have developed enzyme replacements and genetically modified probiotics to treat patients with the rare metabolic disorder.
Immunotherapy More Effective in Men: Study
Immunotherapy More Effective in Men: Study
Kerry Grens | May 18, 2018
Women with metastatic cancer who were treated with a checkpoint inhibitor had a smaller benefit than did men.
FDA Approves Drug to Ease Symptoms of Opioid Withdrawal
FDA Approves Drug to Ease Symptoms of Opioid Withdrawal
Catherine Offord | May 17, 2018
Lucemyra is the first non-opioid drug to be approved in the U.S. specifically for this purpose.
Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data
Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data
Anna Azvolinsky | May 15, 2018
As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull together real-world results.